Topical corticosteroids for vulvar lichen sclerosus
Clobetasol is the most commonly used, but not the only corticosteroid with a role in the treatment of VLS. This guide explains the potency system, the different available corticosteroids, and how they are used in clinical practice.
Classification of topical corticosteroids by potency
Topical corticosteroids are classified into four classes according to their potency, from highest to lowest: Class I (very potent), Class II (potent), Class III (moderate), and Class IV (mild). For VLS, international guidelines recommend starting with Class I corticosteroids — the most potent — due to the intense inflammatory nature of the disease and the difficulty of penetration into vulvar tissue.
Class I — Very Potent (first-line for VLS)
- Clobetasol propionate 0.05% — with the most evidence for VLS
- Betamethasone dipropionate 0.05%
Class II — Potent
- Betamethasone valerate 0.1%
- Mometasone furoate 0.1%
Class II corticosteroids may have a role in the maintenance phase once active disease is controlled with a Class I corticosteroid.
Practical considerations for corticosteroid treatment
Ointment or cream corticosteroid?
For VLS, ointment is generally preferable to cream: it has greater occlusivity, which increases drug penetration into the vulvar tissue. Creams contain excipients that can irritate sensitive vulvar skin.
How much?
A small amount is sufficient — a pea-sized amount covers the entire vulvar area. Excess does not increase efficacy and does increase the risk of side effects.
At what time of day?
Nighttime is the preferred time: the body is at rest, absorption is greater, and contact with clothing or other surfaces that might remove the product is avoided.
Interaction with emollients
If you use a vulvar moisturizer, apply the corticosteroid first and the moisturizer afterward — or in reverse order with a 30-minute separation. Moisturizers applied beforehand can hinder corticosteroid penetration.
The importance of specialized follow-up
Corticosteroid treatment for VLS is not something that is established once and maintained indefinitely. It requires regular follow-up with a specialist to evaluate:
– Clinical response to treatment
– Presence of side effects
– Need to adjust the regimen
– Appearance of any changes requiring attention
Corticosteroid treatment without specialized follow-up is incomplete treatment.